(Reuters Photo)MUMBAI: India has set an ambitious timeline for its first potential coronavirus vaccine — from human trials to general use in six weeks. There has been no evidence yet that Bharat Biotech’s vaccine is safe for use on humans, not to mention effective. The Aug 15 deadline for the Bharat Biotech vaccine may reflect that political pressure: that’s the day India celebrates its Independence from the British, marked by a nationwide address by Modi. Bharat Biotech plans to enroll 375 people in the first phase and 750 people in the second phase of clinical trials, said an ICMR spokesperson. A spokeswoman for Bharat Biotech declined to comment on the Aug 15 timeline in the ICMR letter.

Source: Bangkok Post July 04, 2020 09:22 UTC